Immunomodulatory effect of macrolides: At what cost?
Respir Med Case Rep
; 17: 44-6, 2016.
Article
em En
| MEDLINE
| ID: mdl-27222784
ABSTRACT
We present the case of a 60-year old female patient, with a 10 year history of non-CF bronchiectasis and use of macrolides as maintenance immunomodulatory treatment, who was diagnosed with macrolide-resistant Mycobacterium avium complex lung disease. Macrolides' immunomodulatory effect is appealing for non- CF bronchiectasis patients, hiding a high risk for resistance emergence.
Texto completo:
1
Temas:
ECOS
/
Financiamentos_gastos
Bases de dados:
MEDLINE
Tipo de estudo:
Health_economic_evaluation
Idioma:
En
Revista:
Respir Med Case Rep
Ano de publicação:
2016
Tipo de documento:
Article
País de afiliação:
Grécia